Biotech News
-
Voyageur Pharmaceuticals Ltd. Announces Proposed Private Placement
May 26, 2022 (Source) – Voyageur Pharmaceuticals Ltd. (TSXV:VM) (USA:VYYRF) (the “Company” or “Voyageur”) is pleased to announce that…
-
Zentek Announces Opening of its Industrial Scale ZenGUARD(TM) Production Facility in Guelph, Ontario
May 26, 2022 (Source) – Zentek Ltd. (“Zentek” or the “Company”) (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, is…
-
Awakn Life Sciences Files Patent Cooperation Treaty (PCT) Application for the Treatment of Behavioral Addictions
Successful Behavioral Addiction Study Supplied Data for Patent May 26, 2022 (Source) – Awakn Life Sciences Corp. (NEO:…
-
Sixth Wave AMIPS(TM) Technology 250 Times More Sensitive than Commercial Rapid Antigen Tests in COVID Virus Detection with No Cross-Reactivity
May 24, 2022 (Source) – Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) (“Sixth Wave”, “SIXW” or…
-
Awakn Life Sciences CEO, Anthony Tennyson, Joins Dustin Robinson of Iter Investments for ‘The Investor Hotseat’ via Live Stream on May 26th
May 24, 2022 (Source) – Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (‘Awakn’), a biotechnology company,…
-
Sona Provides Corporate Update
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated April…
-
Hemostemix Announces Financing
February 02, 2022 (Source) — Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (“Hemostemix” or the “Company”) is pleased to announce…
-
Hemostemix Announces Pete Pavlin, P.Eng., Vice-President Operations
May 19, 2022 (Source) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is pleased to…
-
Zentek’s Rapid Diagnostic Platform Receives Two NSERC Grants Towards Commercialization
May 19, 2022 (Source) – Zentek Ltd. (“Zentek” or the “Company”) (NASDAQ:ZTEK; TSX-V:ZEN), an intellectual property development and commercialization company,…
-
Awakn Life Sciences Completes World’s First Ketamine Treatment Study for a Range of Behavioral Addictions
Promising Results Merit Larger Study Which Awakn is Initiating May 19, 2022 (Source) – Awakn Life Sciences Corp. (NEO:…
